8-K: XWELL Inc. Disputes Director Nominations, Cites Deficient Filing by CPC Pain & Wellness

XWELL Inc. has declared the director nominations submitted by CPC Pain & Wellness invalid due to deficiencies in their filing and is urging shareholders to be cautious of communications from CPC.

Summary

• XWELL Inc. has announced that the director nomination notice submitted by CPC Pain & Wellness SPV, LLC is invalid.
• CPC, a special purpose vehicle formed by principals of Caydan Capital Partners, recently acquired a 9.42% stake in XWELL.
• XWELL claims CPC's Schedule 13D filing is deficient and lacks transparency regarding its plans for the company.
• XWELL believes CPC is attempting to gain control of the board to facilitate a transaction involving an underperforming affiliate.
• XWELL has initiated legal action against CPC and is urging shareholders to be cautious of any communications from CPC.
• XWELL is preparing a proxy statement for its 2024 annual meeting of stockholders.

Sentiment

Score: 3

Explanation: The document conveys a negative sentiment due to the ongoing dispute with CPC, the potential for a hostile takeover, and the legal action. This creates uncertainty and risk for investors.

Positives

• XWELL is actively defending itself against what it perceives as a hostile takeover attempt.
• XWELL is providing transparency to its shareholders regarding the situation with CPC.
• XWELL is taking legal action to protect shareholder value.

Negatives

• CPC's actions have created uncertainty and potential instability for XWELL.
• The dispute with CPC could lead to legal costs and distractions for XWELL management.
• There is a risk that CPC's actions could negatively impact XWELL's stock price.

Risks

• The potential for a hostile takeover by CPC could lead to a significant change in XWELL's strategy and operations.
• The legal battle with CPC could be costly and time-consuming.
• The uncertainty surrounding the situation could negatively impact investor confidence in XWELL.
• There is a risk that CPC's proposed transaction could undervalue XWELL and dilute current shareholders.

Future Outlook

XWELL intends to file a proxy statement and a WHITE Proxy Card with the SEC in connection with the Companys 2024 annual meeting of stockholders.

Management Comments

• XWELL calls on CPC to promptly update its Schedule 13D to transparently inform all of the Company's stockholders and the broader investing public of its plans and related legal action.
• XWELL maintains that any such Take-Under deal pursued by CPC could severely undervalue the Company, significantly dilute current stockholders, and siphon tremendous value to CPC and its affiliates.
• XWELL encourages stockholders to be on alert and question any communications from CPC given the entity's actions to date.

Industry Context

This announcement highlights a potential proxy fight, which is not uncommon in the corporate world, especially when a company is perceived as undervalued or when an activist investor seeks to influence the company's direction. The wellness industry is also seeing increased activity and consolidation.

Comparison to Industry Standards

• The situation is similar to other instances where activist investors have sought board representation or control in publicly traded companies.
• The lack of transparency in CPC's filings is a concern, as it deviates from standard disclosure practices expected of investors with significant stakes.
• The potential for a 'take-under' deal is a common tactic used by some investors, but it often raises concerns about fairness and value for existing shareholders.

Legal Proceedings

• XWELL has initiated litigation against CPC in response to their actions.

Stakeholder Impact

• Shareholders are at risk of potential dilution and undervaluation if CPC's plans are successful.
• Employees may experience uncertainty due to the potential changes in company control.
• Customers and suppliers may be indirectly affected by the instability caused by the dispute.

Next Steps

• XWELL will file a proxy statement and a WHITE Proxy Card with the SEC.
• XWELL will continue to dispute CPC's actions and legal filings.
• XWELL will provide updates to shareholders regarding the situation.

Key Dates

Keywords

XWELL, CPC Pain & Wellness, Director Nomination, Proxy Fight, Schedule 13D, Caydan Capital Partners, Board of Directors, Takeover, Litigation, Shareholders